Status:
RECRUITING
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
Lead Sponsor:
Western University, Canada
Conditions:
Bladder Cancer Requiring Cystectomy
Ileal Conduit
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bladder cancer is the 4th most common cancer in men and 5th most common type of cancer in Canada. Urothelial cancer accounts for approximately 90% of malignancies. At diagnosis, over 75% of cases are ...
Eligibility Criteria
Inclusion
- Adult patients (18 years or older) undergoing radical cystectomy and ileal conduit formation for bladder cancer
- Able to give informed written consent to participate.
Exclusion
- Treatment without curative intent (cT4b, salvage or palliative cystectomies);
- Patients undergoing alternative forms of urinary diversion (e.g. continent cutaneous urinary diversion or orthotopic neobladder formation)
- Patients previously received abdominal/pelvic radiotherapy
- Patients with concomitant upper urinary tract cancer
Key Trial Info
Start Date :
November 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06595446
Start Date
November 12 2024
End Date
October 1 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Hospital
London, Ontario, Canada